📊 AI Stock Rating — Summary

Masimo Corporation reported quarterly revenue of $412.5 million with a net income of $68.3 million, translating to an EPS of $1.25. The company exhibited a net margin of 16.6% and generated free cash flow of $43.3 million. On a year-over-year basis, revenue growth appears moderate. Profitability remains solid with efficient cost management reflected in healthy margins. The cash flow quality is robust, backed by operational efficiencies despite substantial cash outflow for stock repurchases, indicating active capital management strategies without dividend payouts. The balance sheet shows a net debt position of $365.7 million against total equity of $721.2 million, representing a cautious approach toward leverage with a debt/equity ratio of 0.51. Analysts set a consensus price target of $187.5, portraying a slightly optimistic sentiment. Overall shareholder returns are strengthened by strategic buybacks, though the lack of recent dividends might affect income-focused investors. Valuation assessments are pending due to unavailable P/E and FCF yield metrics.

AI Score Breakdown

Revenue Growth — Score: 6/10

Moderate growth with stable revenue streams; primary growth driven by consistent demand for healthcare solutions.

Profitability — Score: 8/10

Strong net margins and consistent EPS indicate efficient operations and cost control.

Cash Flow Quality — Score: 7/10

Stable free cash flow unaffected by sizeable buybacks; no recent dividends, impacting income stability.

Leverage & Balance Sheet — Score: 7/10

Prudent leverage reflected in a moderate debt/equity ratio; financial resilience supported by healthy equity.

Shareholder Returns — Score: 6/10

Shareholder value primarily driven by strategic buybacks; absence of recent dividends limits direct returns.

Analyst Sentiment & Valuation — Score: 7/10

Positive analyst sentiment with consensus price targets suggesting upside potential; valuation metrics not fully assessed.

⚠ AI-generated — informational only, not financial advice.